ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
- Tax period
- 2019-01-01 to 2019-12-31
- Filed
- 2020-06-03
- IRS object ID
- 202041559349301614
- Schema version
- 2019v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2020-06-03T15:06:19-05:00 | ReturnTs |
| Tax Period End | 2019-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 050409384 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KAHN LITWIN RENZA & CO LTD | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 951 NORTH MAIN STREET | AddressLine1Txt |
| City | PROVIDENCE | CityNm |
| State Abbreviation | RI | StateAbbreviationCd |
| ZIP | 02904 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2019-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522396428 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ALZHEIMER'S DISEASE RESEARCH FOUNDATION | BusinessNameLine1Txt |
| Business Name Line2 | D/B/A CURE ALZHEIMER'S FUND | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ALZH | BusinessNameControlTxt |
| Phone | 7812373800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST NO 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | TIMOTHY W ARMOUR | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 7812373800 | PhoneNum |
| Signature | 2020-06-03 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | SANDY ROSS | PreparerPersonNm |
| PTIN | P01399337 | PTIN |
| Phone | 4012742001 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 38.111.239.2 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IP | 2020-06-03 | IPDt |
| IP Tm | 14:34:39 | IPTm |
| IP Timezone | ED | IPTimezoneCd |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | 7BF39E0FC1180629874730249EC20B7A78BA7254 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | 161A28E9BA97D9A68C0A4FE47CB342B6FB9ED543 | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2020-09-23 17:36:50Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CURE ALZHEIMER'S FUND | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | TIMOTHY W ARMOUR | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST NO 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $34,576,415 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW. CUREALZ.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2004 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTHROPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 9 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 8 | VotingMembersIndependentCnt |
| Total Employee | 24 | TotalEmployeeCnt |
| Total Volunteers | 68 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $19,798,072 | PYContributionsGrantsAmt |
| CY Contributions Grants | $30,497,342 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $95,723 | PYInvestmentIncomeAmt |
| CY Investment Income | $85,391 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $19,893,795 | PYTotalRevenueAmt |
| CY Total Revenue | $30,582,733 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $16,744,506 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $16,351,728 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $1,766,370 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $2,117,985 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,187,877 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $5,118,435 | PYOtherExpensesAmt |
| CY Other Expenses | $5,838,314 | CYOtherExpensesAmt |
| PY Total Expenses | $23,629,311 | PYTotalExpensesAmt |
| CY Total Expenses | $24,308,027 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$3,735,516 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $6,274,706 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $7,580,826 | TotalAssetsBOYAmt |
| Total Assets EOY | $13,454,870 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $891,589 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $552,268 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $6,689,237 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $12,902,602 | NetAssetsOrFundBalancesEOYAmt |
| Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTHROPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $19,858,076 | ExpenseAmt |
| Grant | $16,351,728 | GrantAmt |
| Desc | IN 2019, CURE ALZHEIMER'S FUND SUPPORTED 74 RESEARCH PROJECTS AT 36 LEADING RESEARCH INSTITUTIONS, FOR A FUNDING TOTAL OF MORE THAN $19 MILLION. MANY PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT, IN PARTICULAR REGARDING THE ROLL OF THE BRAIN'S INNATE IMMUNE SYSTEM. ADDITIONAL EXPENSES INCLUDE DEVELOPMENT AND BREEDING OF TRANSGENIC ANIMAL MODELS BY A CONTRACT RESEARCH ORGANIZATION; THE DIRECT SUPPORT OF FACILITATING GRANTS AND THE AWARD PROCESS; AND COSTS ASSOCIATED WITH HOSTING SCIENTIFIC MEETINGS. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $2,316,970 | ExpenseAmt |
| Desc | CREATING AWARENESS TOOK THE FORM OF MAILINGS, OUTREACH, AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $22,175,046 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 33 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 24 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 9 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 8 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TIMOTHY W ARMOUR | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 7812383800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON STREET STE 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (14 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd |
|---|---|---|---|---|---|---|---|
| JEFFREY MORBY | |||||||
| CO-CHAIRMAN | 20.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| HENRY MCCANCE | |||||||
| CO-CHAIRMAN | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| PHYLLIS RAPPAPORT | |||||||
| TREASURER | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| BILL BENTER | |||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | ||
| ROBERT GREENHILL | |||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | ||
| JAY JESTER | |||||||
| DIRECTOR | 5.00 | Yes (X) | $0 | $0 | $0 | ||
| JACQUELINE MORBY | |||||||
| DIRECTOR | 5.00 | Yes (X) | $0 | $0 | $0 | ||
| SHERRY SHARP | |||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | ||
| TIMOTHY ARMOUR | |||||||
| PRESIDENT & CEO | 40.00 | Yes (X) | Yes (X) | $258,333 | $0 | $9,408 | |
| MARGARET SMITH | |||||||
| SECRETARY & SR VP | 20.00 | Yes (X) | $133,719 | $0 | $5,000 | ||
| BARBARA CHAMBERS | |||||||
| SENIOR VICE PRESIDENT | 40.00 | $181,416 | $0 | $15,871 | Yes (X) | ||
| SALLY G ROSENFIELD | |||||||
| SENIOR VICE PRESIDENT | 40.00 | $167,419 | $0 | $11,467 | Yes (X) | ||
| JOHN SLATTERY | |||||||
| SENIOR VICE PRESIDENT | 40.00 | $178,356 | $0 | $6,798 | Yes (X) | ||
| KATHERINE HERMAN | |||||||
| EXECUTIVE VICE PRESIDENT (AS OF 09/19) | 40.00 | Yes (X) | $148,734 | $0 | $9,019 | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,067,977 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $57,563 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 6 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (4 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| PROPER VILLIANS INC | |||||
| 668 STONY HILL RD | YARDLEY | MA | 19067 | CREATIVE SERVICES | $227,885 |
| GRYPHON CONSULTING INC | |||||
| 21 DEAN ST | BELMONT | MA | 02478 | FINANCIAL & MGT CONSULTANT | $171,409 |
| CHOATE HALL & STEWART | |||||
| TWO INTERNATIONAL PLACE | BOSTON | MA | 02110 | LEGAL FEES | $120,512 |
| RUBENSTEIN | |||||
| 825 EIGHTH AVENUE | NEW YORK | NY | 10019 | STRATEGIC COMMUNICATIONS | $120,154 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 4 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $30,497,342 | AllOtherContributionsAmt |
| Noncash Contributions | $4,985,904 | NoncashContributionsAmt |
| Total Contributions | $30,497,342 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $83,306 | TotalRevenueColumnAmt |
| Exclusion | $83,306 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $3,995,767 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $3,993,682 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $2,085 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,085 | TotalRevenueColumnAmt |
| Exclusion | $2,085 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $30,582,733 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $85,391 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,431,965 | TotalAmt |
| Program Services | $15,431,965 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $919,763 | TotalAmt |
| Program Services | $919,763 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $562,913 | TotalAmt |
| Program Services | $326,490 | ProgramServicesAmt |
| Management And General | $106,953 | ManagementAndGeneralAmt |
| Fundraising | $129,470 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,291,433 | TotalAmt |
| Program Services | $779,604 | ProgramServicesAmt |
| Management And General | $225,629 | ManagementAndGeneralAmt |
| Fundraising | $286,200 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $34,861 | TotalAmt |
| Program Services | $20,970 | ProgramServicesAmt |
| Management And General | $6,141 | ManagementAndGeneralAmt |
| Fundraising | $7,750 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $93,814 | TotalAmt |
| Program Services | $55,796 | ProgramServicesAmt |
| Management And General | $16,933 | ManagementAndGeneralAmt |
| Fundraising | $21,085 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $134,964 | TotalAmt |
| Program Services | $86,192 | ProgramServicesAmt |
| Management And General | $21,738 | ManagementAndGeneralAmt |
| Fundraising | $27,034 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $120,513 | TotalAmt |
| Program Services | $61,670 | ProgramServicesAmt |
| Management And General | $35,299 | ManagementAndGeneralAmt |
| Fundraising | $23,544 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $162,328 | TotalAmt |
| Management And General | $162,328 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $107,124 | TotalAmt |
| Program Services | $107,124 | ProgramServicesAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $40 | TotalAmt |
| Management And General | $40 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $889,014 | TotalAmt |
| Program Services | $702,877 | ProgramServicesAmt |
| Management And General | $70,988 | ManagementAndGeneralAmt |
| Fundraising | $115,149 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $103,567 | TotalAmt |
| Program Services | $65,838 | ProgramServicesAmt |
| Fundraising | $37,729 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $225,712 | TotalAmt |
| Program Services | $69,684 | ProgramServicesAmt |
| Management And General | $62,593 | ManagementAndGeneralAmt |
| Fundraising | $93,435 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $82,712 | TotalAmt |
| Program Services | $6,707 | ProgramServicesAmt |
| Management And General | $76,005 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $185,495 | TotalAmt |
| Program Services | $110,212 | ProgramServicesAmt |
| Management And General | $33,554 | ManagementAndGeneralAmt |
| Fundraising | $41,729 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $239,944 | TotalAmt |
| Program Services | $112,165 | ProgramServicesAmt |
| Management And General | $36,862 | ManagementAndGeneralAmt |
| Fundraising | $90,917 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $555,824 | TotalAmt |
| Program Services | $361,607 | ProgramServicesAmt |
| Management And General | $51,764 | ManagementAndGeneralAmt |
| Fundraising | $142,453 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,756 | TotalAmt |
| Management And General | $11,756 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,179 | TotalAmt |
| Program Services | $3,812 | ProgramServicesAmt |
| Management And General | $11,367 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| RESEARCH LAB EXPENSES | $2,936,648 | $2,936,648 | ||
| GIFT PROCESSING FEES | $139,534 | $159 | $139,375 | |
| MISCELLANEOUS | $62,924 | $15,922 | $14,995 | $32,007 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,308,027 | TotalAmt |
| Program Services | $22,175,046 | ProgramServicesAmt |
| Management And General | $945,104 | ManagementAndGeneralAmt |
| Fundraising | $1,187,877 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,352,595 | BOYAmt |
| EOY | $4,437,174 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $148,396 | BOYAmt |
| EOY | $1,293,996 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $785,013 | BOYAmt |
| EOY | $6,309,700 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $259,681 | BOYAmt |
| EOY | $65,952 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $54,458 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $27,863 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,351 | BOYAmt |
| EOY | $26,595 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,996,790 | BOYAmt |
| EOY | $1,321,453 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,580,826 | BOYAmt |
| EOY | $13,454,870 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $392,536 | BOYAmt |
| EOY | $143,095 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $499,053 | BOYAmt |
| EOY | $409,173 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $891,589 | BOYAmt |
| EOY | $552,268 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,466,208 | BOYAmt |
| EOY | $6,344,297 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,223,029 | BOYAmt |
| EOY | $6,558,305 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,689,237 | BOYAmt |
| EOY | $12,902,602 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,580,826 | BOYAmt |
| EOY | $13,454,870 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $6,274,706 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$61,341 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,248,214 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $16,220,862 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $17,501,551 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $19,798,072 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $30,497,342 | CurrentTaxYearAmt |
| Total | $95,266,041 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,248,214 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $16,220,862 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $17,501,551 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $19,798,072 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $30,497,342 | CurrentTaxYearAmt |
| Total | $95,266,041 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $10,624,098 | SubstantialContributorsTotAmt |
| Public Support Total170 | $84,641,943 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $764 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $611 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $13,021 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $77,320 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $83,306 | CurrentTaxYearAmt |
| Total | $175,022 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,150 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $90 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,644 | CurrentTaxYearMinus2YearsAmt |
| Total | $6,884 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $95,447,947 | TotalSupportAmt |
| Public Support CY170 | 0.88680 | PublicSupportCY170Pct |
| Public Support PY170 | 0.86580 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | VolunteersInd |
| Paid Staff Or Management | 0 | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | 0 | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (1) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $107,124 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | 0 | OtherActivitiesInd |
| Total Lobbying Expenditures | $107,124 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-B, LINE 1(G) | FormAndLineReferenceDesc |
| Explanation | A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH BY THE FEDERAL GOVERNMENT. | ExplanationTxt |
Schedule D IRS990ScheduleD
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $54,458 | OtherCostOrOtherBasisAmt |
| Depreciation | $27,863 | DepreciationAmt |
| Book Value | $26,595 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $26,595 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | ACCRUED EXPENSE | Desc |
| Amt | $409,173 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $409,173 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $30,521,352 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$61,341 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | -$61,341 | RevenueNotReportedAmt |
| Revenue Subtotal | $30,582,693 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $40 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $40 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $30,582,733 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $24,307,987 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $24,307,987 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $40 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $40 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $24,308,027 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION IS EXEMPT FROM INCOME TAXES AS A PUBLIC CHARITY UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. MANAGEMENT BELIEVES THAT THE ORGANIZATION OPERATES IN A MANNER CONSISTENT WITH ITS TAX-EXEMPT STATUS AT BOTH THE STATE AND FEDERAL LEVEL. THE ORGANIZATION ANNUALY FILES IRS FORM 990- RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX REPORTING VARIOUS INFORMATION THAT THE IRS USES TO MONITOR THE ACTIVITIES OF TAX-EXEMPT ENTITIES. THESE TAX RETURNS ARE SUBJECT TO REVIEW BY THE TAXING AUTHORITIES, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THEY WERE FILED. THE ORGANIZATION CURRENTLY HAS NO TAX EXAMINATIONS IN PROGESS. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | RegionTxt |
| Offices | 0 | OfficesCnt |
| Employee | 0 | EmployeeCnt |
| Type Of Activities Conducted | GRANTS AWARDED | TypeOfActivitiesConductedTxt |
| Specific Services Provided | ALZHEIMER'S DISEASE RESEARCH | SpecificServicesProvidedTxt |
| Region Total Expenditures | $919,763 | RegionTotalExpendituresAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $919,763 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $919,763 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (6 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | IDENTIFYING NOVEL EPIGENETIC BIOMARKERS OF HUMAN COGNITIVE AGING. | $171,875 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | THERAPEUTIC MODULATION OF TREM2 ACTIVITY | $150,000 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | ASSESSMENT OF ANTIBODY-BASED DRUG TRAFFICKING ACROSS THE BBB VIA SULL-MENINGES CONNECTIONS. | $115,000 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | GENE EXPRESSION THROUGHOUT DEVELOPMENT OF PATHOLOGY IN APPKI MICE; EFFECTS OF HUMAN TAU AND AGEING. | $195,388 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | UNDERSTANDING MOLECULAR BIOMARKER CHANGES IN ALZHEIMER'S DISEASE USING GENETICALLY-DEFINED MOUSE MODELS. | $172,500 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | PATCH-SEQ ANALYSIS OF THE CHOROID PLEXUS EPITHELIAL CELL BARRIER IN HOMEOSTASIS AND IN AD | $115,000 | CHECK |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 6 | Total501c3OrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART III ACCOUNTING METHOD: | FormAndLineReferenceDesc |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (67 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | IRC SectionIRCSectionDesc |
|---|---|---|---|---|---|---|---|
| AMYLYX | |||||||
| 43 THORNDIKE ST | CAMBRIDGE | MA | 02141 | 464600503 | $750,000 | PEGASUS CLINICAL STUDY OF AMX0035 IN ALZHEIMERS DISEASE; DRUG DEVELOPEMENT | |
| BETH ISRAEL DEACONESS MEDICAL CENTER | |||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042103881 | $172,500 | UTILIZING FUNCTIONAL MAPS TO DISCOVER MICRO RNA'S IN AD | 501 (C)(3) |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | $345,000 | THE ROLE OF MFND-NEAURODEGENERATIVE CLEC7A+MICROGLIA IN AN AD MOUSE MODEL; TARGETING THE MICROBIOME AND MICROGLIA IN AD | 501 (C)(3) |
| CARNEGIE MELLON UNIVERSITY | |||||||
| 4400 FIFTH AVE | PITTSBURGH | PA | 15213 | 250969449 | $199,013 | CIRCUITS: INTERPRETING ALZHEIMER'S DISEASE-ASSOCIATED GENETIC VARIATION AT ENHANGER REGION | 501 (C)(3) |
| BOSTON CHILDRENS HOSPITAL | |||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 042774441 | $298,115 | MICROGLIAL HETEROGENEITY AND TRANSCIPTIONAL STATE CHANGES IN ALZHEIMER'S DISEASE. | 501 (C)(3) |
| COLUMBIA UNIVERSITY | |||||||
| 710 WEST 168TH STREET 3RD FLOOR | NEW YORK | NY | 10032 | 135598093 | $83,375 | 2019 FITZPATRICK PETRUCELLI: PT BASED STRUCTURAL AND FUNCTIONAL BIOLOGY OF TAUOPATHIES | 501 (C)(3) |
| DUKE UNIVERSITY SCHOOL OF MEDICINE | |||||||
| 324 BLACKWELL ST WASHINGTON BLDG | DURHAM | NC | 27701 | 562247203 | $91,687 | A NOVEL APOE MIMETIC THERAPEUTIC PEPTIDE CN-105 ATTENUATES AD PATHOLOGY AND IMPROVES FUNCATIONAL OUTCOMES IN A MURINE MODEL OF AD | 501 (C)(3) |
| HARVARD COLLEGE | |||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 042103580 | $250,000 | ASSESSING THE LINKS BETWEEN THE MS4A RISK GENESE, MICROGLIA, AND ALZHEIMER'S DISEASE | 501 (C)(3) |
| HARVARD COLLEGE | |||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 042103580 | $171,523 | ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE | 501 (C)(3) |
| HARVARD COLLEGE | |||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 042103580 | $172,500 | ACTIVATION OF THE 26S PROTEASOME FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 501 (C)(3) |
| HOUSTON METHODIST HOSPITAL FOUNDATION | |||||||
| PO BOX 4384 | HOUSTON | TX | 77210 | 760094743 | $287,500 | UNCOVERING THE MOLECULAR MECHANISM OF SELECTED DRUG CANDIDATES DERIVED FROM SYSTEMATIC ALZHEIMER'S DRUG REPOSITIONING | 501 (C)(3) |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||
| BOX 1049 GUSTAVE L LEVY PLACE | NEW YORK | NY | 10026 | 136171197 | $150,000 | VGF, A NOVEL THERAPEUTIC EFFECTOR OF AD PATHOGENESIS AND PROGRESSION | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | IMAGING MICROGLIAL HOMEOSTASIS AND DISRUPTION P2RY12 RADIOTRACER DEVELOPMENT | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,443 | DIRECT MIGRATION OF MYELOID CELLS FROM THE SKULL MARROW TO THE BRAIN THROUGH ANATOMICAL CHANNELS ADDING FUEL TO THE FILE IN AD | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $115,000 | HUMAN 3D NEURO-VASCULAR INTERACTION AND MENINGEAL LYMPHATIC MODELS WITH APPLICATION TO AD | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $250,000 | NEUROIMMUNE MOLECULAR IMAGING: REDEFINING THE LANDSCAPE OF OPPORTUNITIES IN AD | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $300,000 | UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $108,726 | AN INNOVATIVE STUDY OF THE PUPIL LIGHT REFLEX IN AD | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $350,000 | TAU AND B-AMYLOID ARE INNATE IMMUNE ANTIMICROBIAL PEPTIDES IN THE BRAIN | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $345,000 | INHIBITING CD33 FUNCTION AND MODULATING MICROGLIAL ACTIVATION STATE FOR ALZHEIMER'S DISEASE THERAPY | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $287,500 | HIGH THROUGH PUT DRUG SCREENING FOR AD USING 3D HUMAN NEURAL CULTURE SYSTEMS | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $172,500 | GENES TO THERAPIES CENTRALIZED RESEARCH CORE | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $171,914 | INTERLEUKIN-3 IN AD | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $250,000 | GUT MICROBIOME MEDIATED SHIFTS IN B-AMYLOID DEPOSITION IN A HUMANIZED AD MOUSE MODEL | 501 (C)(3) |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 041564655 | $1,475,000 | ALZHEIMER'S GENOME PROJECT | 501 (C)(3) |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | |||||||
| 77 MASSACHUSETTS AVE | CAMBRIDGE | MA | 02139 | 042103594 | $100,000 | HUMAN 3D NEURO-VASCULAR INTERACTION AND MENINGEAL LYMPHATICS MODELS WITH APPLICATION TO AD | 501 (C)(3) |
| MAYO CLINIC | |||||||
| 200 FIRST ST SW | ROCHESTER | MN | 55905 | 416011702 | $172,500 | THE ROLE OF CLUSTERIN IN TAU PATHOLOGY | 501 (C)(3) |
| MAYO CLINIC JACKSONVILLE | |||||||
| 4500 SAN PABLO ROAD S | JACKSONVILLE | FL | 32224 | 593337028 | $172,500 | 2019 FITZPATRICK PETRUCELLI: PT-BASE STRUCTURAL AND FUNCTIONAL BIOLOGY OF TAUOPATHIES. | 501 (C)(3) |
| MEMORIAL SLOAN KETTERING CANCER CENTER | |||||||
| PO BOX 27106 | NEW YORK | NY | 10087 | 131924236 | $150,000 | BIOCHEMICAL MAPPTING OF THE GSM BINDING SITE OF THE NOVEL PYRIDAZINE-DERIVED SMALL MOLECULE Y-SECRETASE MODULARS | 501 (C)(3) |
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | |||||||
| 550 1ST AVE R607 | NEW YORK | NY | 10016 | 135562308 | $250,000 | NEUROTOXIC REACTIVE ASTROCYES IN ALZHEIMER'S DISEASE | 501 (C)(3) |
| NORTHWESTERN UNIVERSITY | |||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 362167817 | $115,000 | THE ROLE OF IMPAIRED SYNAPTIC VESICLE MACHINERY PROTEOSTATSIS IN ALZHEIMER'S DISEASE PATHOGENESIS | 501 (C)(3) |
| NORTHWESTERN UNIVERSITY | |||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 362167817 | $250,000 | MOLECULAR AND CELLULAR MECHANISMS OF ACE1 R1279Q IN AD | 501 (C)(3) |
| PALO ALTO VETERANS INSTITUTE FOR RESEARCH | |||||||
| 3801 MIRANDA AVE 101-A2-210 | PALO ALTO | CA | 94304 | 770207331 | $172,500 | REJUVENATION OF MICROGLIA IN BRAIN AGING AND NEURODEGENERATION | 501 (C)(3) |
| SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE | |||||||
| 10901 N TORREY PINES RD | LA JOLLA | CA | 92037 | 510197108 | $172,500 | MECHANISMS FOR AD-ASSOCIATED DORLA MUTATIONS IN MICROGLIA AND NEURONS IN AD PATHOGENESIS | 501 (C)(3) |
| THE BROAD INSTITUTE INC | |||||||
| 415 MAIN ST | CAMBRIDGE | MA | 02142 | 263428781 | $750,000 | PRODUCTION CENTER FOR REFERENCE AND VARIATION GENE-REGULARTORY MAPS | 501 (C)(3) |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 1111 FRANKLIN ST 12TH FLOOR | OAKLAND | CA | 94607 | 943067788 | $150,000 | TREATING WITH GAMMA-SECRETASE MODULATORS TO PREVENT NEAURDENERATION IN MOUSE MODELS OF DOWN SYNDROME AND AD | 501 (C)(3) |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 1111 FRANKLIN ST 12TH FLOOR | OAKLAND | CA | 94607 | 943067788 | $250,000 | INTERPRETATION OF NON-CODING RISK ALLELES OF AD | 501 (C)(3) |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 1111 FRANKLIN ST 12TH FLOOR | OAKLAND | CA | 94607 | 943067788 | $172,500 | HUMAN-SPECIFIC EVOLUTION OF CD33: EVOLUTIONARY RELATIONSHIP TO ANCIENT HOST-PATHOGEN INTERACTIONS AND CURRENT IMPLICATION FOR ALZHEIMER'S DISEASE | 501 (C)(3) |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 1111 FRANKLIN ST 12TH FLOOR | OAKLAND | CA | 94607 | 943067788 | $150,000 | BIOCHEMICAL MAPPING OF THE GSM BINDING SITE OF THE NOVEL PYRIDAZINE-DERIVED SMALL MOLECULE Y-SECRETASE MODULATORS | 501 (C)(3) |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 1111 FRANKLIN ST 12TH FLOOR | OAKLAND | CA | 94607 | 943067788 | $287,500 | ALZHEIMERS DISEASE-ASSOCIATED MUTATIONS IN PROTEIN KINASE C | 501 (C)(3) |
| THE ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10065 | 131624158 | $172,500 | DISCOVERY OF CHEMICAL COMPOUNDS THAT INDUCE DEGRADATION OF APP-B-CTF IN CELLS | 501 (C)(3) |
| THE ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10065 | 131624158 | $150,000 | STIMULATING PROTEASOME ACTIVITY FOR THE TREATMENT OF AD | 501 (C)(3) |
| THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | |||||||
| 10010 N TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | $115,000 | IMPACT OF GENETIC, EPIGENETIC AND CELLULAR VARIANTS ON AD PATHOLOGY. | 501 (C)(3) |
| THE TRUSTEES OF BOSTON UNIVERSITY | |||||||
| 25 BUICK STREET | BOSTON | MA | 02115 | 042103547 | $172,500 | EVALUATION OF THE EFFECT OF CELL TYPE- SPECIFIC DELETION OF ESCRT GENES ON THE SPREAD OF TAU PATHOLOGY | 501 (C)(3) |
| THE TRUSTEES OF BOSTON UNIVERSITY | |||||||
| 25 BUICK STREET | BOSTON | MA | 02115 | 042103547 | $172,500 | AD PHARMACOMICS IN 3D | 501 (C)(3) |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||
| 9500 GILMAN RIVE | LA JOLLA | CA | 92093 | 952872494 | $237,500 | IDENTIYING THE BLOOD BRAIN BARRIER CHANGES DURING AD | 501 (C)(3) |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||
| 9500 GILMAN RIVE | LA JOLLA | CA | 92093 | 952872494 | $230,000 | THE EFFECT OF CHRONIC GAMMA-SECRETED MODULATION ON THE PREVENTION OF TBI-PROVOKED AND AD-RELEVANT BIOCHEMICAL PATHOLOGICAL AND BEHAVIORAL ALTERATIONS | 501 (C)(3) |
| UNIVERSITY OF CONNECTICUT HEALTH CENTER | |||||||
| 263 FARMINGTON AVE | FARMINGTON | CT | 06030 | 237187838 | $172,500 | PHYSIOLOGICAL METHOD FOR EARLY DETECTION OF SYNAPTIC VULNERABILITY IN AD MODEL ANIMALS | 501 (C)(3) |
| UNIVERSITY OF CHICAGO | |||||||
| 5235 S HARPER COURTH 4TH FLOOR | CHICAGO | IL | 60615 | 362177139 | $200,000 | IN VITRO AND IN VIVO ANALYSIS OF AN APP VARIANT | 501 (C)(3) |
| UNIVERSITY OF RHODE ISLAND | |||||||
| 75 LOWER COLLEGE RD STE 001 | KINGSTON | RI | 02881 | 364644408 | $56,404 | CEREBROVASCULAR DYSFUNCTION IN AD: TARGETING THE MECHANISMS OF VASCULAR ACTIVATION | 501 (C)(3) |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||
| UNIVERSITY PARK | LOS ANGELES | CA | 90089 | 951642394 | $172,565 | THE ROLE OF TREM2, APOE AND SEX | 501 (C)(3) |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||
| UNIVERSITY PARK | LOS ANGELES | CA | 90089 | 951642394 | $345,000 | MOLECULAR SIGNATURES OF APOE-MEDIATED BLOOD BRAIN BARRIER DYSFUNCTION CAUSING NEURONAL AND SYNAPTIC DYSFUNCATION | 501 (C)(3) |
| UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | |||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 752556007 | $172,500 | GENETIC TARGETS TO BLOCK TAU PROPAGATION: TEST KNOCKDOWN OF HSPG GENES IN VIVO | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $345,000 | ROLE IN MODULATING AB AND TAU-RELATED PATHOLOGIES AND NEURODENERATION | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $150,000 | TARGETING REACTIVE ASTOCYTES FOR THERAPEUTIC INTERVENTION OF AD | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $172,500 | MODELING AD IN SPECIFIC SUBTYPES OF HUMAN NEURONS THROUGH DIRECT NEURONAL REPROGRAMMING OF PATIENT FIBROBLASTS. | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $150,000 | STABLE ISOTOPE LABELING & QUANTITATIVE MASS SPECTOMETRY IMAGING OF AD PATHOLOGY IN HUMAN BRAIN | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $154,701 | CENTRAL CLOCK INFLUENCE ON ALZHEIMER'S DISEASE PATHOGENESIS | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $172,500 | HARNESSING BIG DATA TO UNDERSTAND AD RISK | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $103,016 | CHARACTERIZATION OF AD MOLECULAR BIOMARKER PROFILES THROUGHOUT THE PATHOBIOLOICAL CONTINUUM | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $345,000 | BERG BRAIN ENTRY & EXIT CONSORTIUM: CROSSTALK OF DNS BARRIERS AND CLEARANCE ROUTES IN HOMEOSTASIS AND AD | 501 (C)(3) |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 63112 | 430653611 | $172,497 | THE CIRCADIAN CLOCK MODULATES NEURODENERATION IN AD VIA REVE-ERB | 501 (C)(3) |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | |||||||
| 1167 YORK AVE | NEW YORK | NY | 10065 | 136094042 | $173,486 | AD RISK IS HIGHER IN WOMEN: IDENTIFICATION OF FEMALE SPECIFIC BRAIN BIOENERGETIC TARGETS | 501 (C)(3) |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | |||||||
| 1167 YORK AVE | NEW YORK | NY | 10065 | 136094042 | $150,000 | REGULATION OF MIRCOGLIAL LYSOSOME ACIDIFICATION | 501 (C)(3) |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | |||||||
| 1167 YORK AVE | NEW YORK | NY | 10065 | 136094042 | $172,500 | DIETARY SALT TAU PHOSPHRYLATION AND COGNITIVE IMPAIRMENT | 501 (C)(3) |
| WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | |||||||
| 9 CAMBRIDGE CENTER | CAMBRIDGE | MA | 02142 | 061043412 | $172,500 | IMPACT OF GENETIC, EPIGENETIC AND CELLULAR VARIANTS ON AD PATHOLOGY | 501 (C)(3) |
| YALE UNIVERSITY | |||||||
| 333 CEDAR ST | NEW HAVEN | CT | 06510 | 060646973 | $172,500 | ROLE OF MICROGLIAL PROTEIN SPARC IN CONTROL OF INFLAMMASOME ACTIVATION | 501 (C)(3) |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE RESEARCH LEADERSHIP GROUP REVIEWS EACH PROPOSAL FOR FIT WITH THE CURE ALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S DISEASE. ALL FUNDED RESEARCHERS MAY BE ASKED TO REVIEW OCCASIONAL PROPOSALS ON A THREE-WEEK TIMELINE AS A CONDITION OF RECEIVING FUNDING. THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT PROPOSAL FITS WITHIN THE ORGANIZATION'S MISSION TO FUND RESEARCH CONTRIBUTING TO A CURE FOR ALZHEIMER'S DISEASE. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY REVIEWER MAY RESULT IN A REQUEST FOR ITERATION OR REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTIONS, OR REJECTION BUT WILL NOT RECEIVE ANY "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION IF A PROPOSAL IS FUNDED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TIMOTHY ARMOUR | ||||||||||||||
| PRESIDENT & CEO | $258,333 | $0 | $0 | $0 | $0 | $0 | $9,408 | $0 | $0 | $0 | $267,741 | $0 | $0 | $0 |
| BARBARA CHAMBERS | ||||||||||||||
| SENIOR VICE PRESIDENT | $181,416 | $0 | $0 | $0 | $0 | $0 | $7,142 | $0 | $8,729 | $0 | $197,287 | $0 | $0 | $0 |
| SALLY G ROSENFIELD | ||||||||||||||
| SENIOR VICE PRESIDENT | $167,419 | $0 | $0 | $0 | $0 | $0 | $6,782 | $0 | $4,685 | $0 | $178,886 | $0 | $0 | $0 |
| JOHN SLATTERY | ||||||||||||||
| SENIOR VICE PRESIDENT | $178,356 | $0 | $0 | $0 | $0 | $0 | $6,798 | $0 | $0 | $0 | $185,154 | $0 | $0 | $0 |
| KATHERINE HERMAN | ||||||||||||||
| EXECUTIVE VICE PRESIDENT (AS OF 09/1 | $148,734 | $0 | $0 | $0 | $0 | $0 | $5,074 | $0 | $3,945 | $0 | $157,753 | $0 | $0 | $0 |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 77 | ContributionCnt |
| Noncash Contributions Rpt F990 | $4,985,904 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | SALE PRICE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (1) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 32B: | FormAndLineReferenceDesc |
| Explanation | WHEN STOCK IS RECEIVED AS A CONTRIBUTION IT IS SOLD IMMEDIATELY UPON RECEIPT OR SOON THEREAFTER AS IS PRACTICAL THROUGH BANK OF NEW YORK/MELLON. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | JEFFREY MORBY AND JACQUELINE MORBY ARE BOTH DIRECTORS AND SPOUSES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS PREPARED BY THE EXTERNAL AUDITORS AND REVIEWED BY THE PRESIDENT AND CONTRACT CFO. REVISIONS, CORRECTIONS, ETC. ARE MADE AS NECESSARY. ONCE ALL ARE SATISFIED WITH THE FORM, IT IS FINALIZED AND A COPY IS SENT TO ALL BOARD MEMBERS. |
| FORM 990, PART VI, SECTION B, LINE 12C | EACH YEAR THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED TO ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES. THESE PEOPLE ARE ASKED TO REVIEW THE POLICY AND SIGN A STATEMENT INDICATING THAT THEY UNDERSTAND THE POLICY AND HAVE REPORTED ALL POTENTIAL CONFLICTS DURING THE PAST YEAR IN ACCORDANCE WITH THE POLICY AND WILL REPORT ALL POTENTIAL CONFLICTS DURING THE COMING YEAR. ALL POTENTIAL CONFLICTS ARE EVALUATED BY THE BOARD TO DETERMINE IF A CONFLICT ACTUALLY EXISTS. IN THOSE INSTANCES WHERE THE POTENTIAL TRANSACTION IS A CONFLICT, THE BOARD EXAMINES THE TRANSACTION AND A VOTE IS TAKEN (WITH THOSE INVOLVED RECUSING THEMSELVES) AS TO WHETHER THE ORGANIZATION WILL ENTER INTO THE TRANSACTION. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPARABILITY DATA IS SUBMITTED ANNUALLY TO THE EXECUTIVE COMMITTEE FOR COMPENSATION APPROVAL FOR THE PRESIDENT AND ALL OTHER EMPLOYERS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND AT THE ORGANIZATION'S WEBSITE. |
Comments